Medicare Enrolled

Dr. Luay Sarsam, M.D.

Internal Medicine · Chula Vista, CA
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Low-engagement
765 MEDICAL CENTER CT STE 211, Chula Vista, CA 91911
6196162100
In practice since 2015 (10 years)
NPI: 1558744953 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sarsam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarsam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sarsam

Dr. Luay Sarsam is an internal medicine specialist in Chula Vista, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Sarsam performed 764 Medicare services across 596 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sarsam received a total of $10,570 from 30 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sarsam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 41% volume in CA $10,570 industry payments

Medicare Practice Summary

Medicare Utilization ↗
764
Medicare services
Top 41% in CA for internal medicine
596
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~76 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
125 $98 $244
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
102 $107 $294
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
93 $172 $466
Heart muscle strain imaging 75 $33 $98
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
70 $12 $55
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
68 $44 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
49 $131 $378
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
47 $143 $447
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
36 $245 $1,639
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
18 $401 $1,266
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
18 $62 $275
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
18 $1 $20
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
15 $21 $60
30-day continuous ECG with patient-triggered event transmission and review
This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report.
15 $770 $1,946
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $71 $192
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.5% high complexity
28.1% medium
57.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,570
Total received (2018-2024)
Avg $1,510/year across 7 years
Top 9% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,035 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$535 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,842
2023
$2,559
2022
$3,784
2021
$1,091
2020
$326
2019
$590
2018
$378

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HEARTFLOW, INC.
$271
AstraZeneca Pharmaceuticals LP
$267
ABIOMED
$242
Abbott Laboratories
$162
Boston Scientific Corporation
$155
Alnylam Pharmaceuticals Inc.
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Novartis Pharmaceuticals Corporation
$74
E.R. Squibb & Sons, L.L.C.
$72
Actelion Pharmaceuticals US, Inc.
$72
Kiniksa Pharmaceuticals International, plc
$63
Merck Sharp & Dohme LLC
$60
CVRx, Inc.
$41
Kestra Medical Technology Services, Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$35
SCPHARMACEUTICALS INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$4,157
CVRx, Inc.
$956
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$766
AstraZeneca Pharmaceuticals LP
$737
ABIOMED
$680
Actelion Pharmaceuticals US, Inc.
$417
Alnylam Pharmaceuticals Inc.
$370
Bayer HealthCare Pharmaceuticals Inc.
$310
Boston Scientific Corporation
$303
Novartis Pharmaceuticals Corporation
$276
HEARTFLOW, INC.
$271
Merck Sharp & Dohme LLC
$222
Edwards Lifesciences Corporation
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
United Therapeutics Corporation
$144
E.R. Squibb & Sons, L.L.C.
$109
Janssen Pharmaceuticals, Inc
$101
BIOTRONIK INC.
$83
Nuwellis, Inc.
$78
Kiniksa Pharmaceuticals International, plc
$63
Kestra Medical Technology Services, Inc.
$40
Kiniksa Pharmaceuticals, Ltd.
$38
SCPHARMACEUTICALS INC.
$32
Alexion Pharmaceuticals, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$18
Daiichi Sankyo Inc.
$15
Lantheus Medical Imaging, Inc.
$14
Novo Nordisk Inc
$14
Medtronic Vascular, Inc.
$11
PORTOLA PHARMACEUTICALS, INC.
$11
Top 3 companies account for 55.6% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ANDEXXA · AVEIR · Adempas · Aquadex Smartflow Console · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CardioMEMS HF System · Definity · ELIQUIS · ENTRESTO · EP-WorkMate Claris System · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FFRct · FUROSCIX · Fortify Assura · GALLANT · INJECTAFER · Impella · Inquiry Steerable Catheters · JARDIANCE · Kerendia · LEQVIO · LifeVest · MITRACLIP · OPSUMIT · ORENITRAM · Ozempic · PIFELTRO · REMODULIN · Strensiq · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TactiCath Quartz CFA Catheter · UPTRAVI · VERQUVO · Verquvo · VersaCross Access Solution · WAINUA · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in CA.

Looking for an internal medicine specialist in Chula Vista?
Compare internal medicine physicians in the Chula Vista area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,387
Per 100K population
42.3
County median income
$102,285
Nearest hospital
SHARP CHULA VISTA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sarsam is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sarsam experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Sarsam performed 125 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sarsam receive payments from pharmaceutical companies?
Yes. Dr. Sarsam received a total of $10,570 from 30 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarsam's costs compare to other internal medicine physicians in Chula Vista?
Dr. Sarsam's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarsam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →